Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects

被引:29
作者
Bick, RL
机构
[1] Univ Texas, SW Med Ctr, Dept Med & Pathol, Dallas, TX 75231 USA
[2] Dallas Thrombosis Hemostasis Clin Ctr, Dallas, TX 75231 USA
[3] ThromboCare Labs, Dallas, TX 75231 USA
关键词
D O I
10.1016/S0889-8588(02)00101-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The defects described in this article are not as common as factor V Leiden, but they are more common than many other hereditary procoagulant defects. The incidence of the prothrombin gene (G20210A) mutation is not yet known with certainty, but it may approach or even exceed that of factor V Leiden. These defects also seem less common than hereditary sticky platelet syndrome; however, they always should be considered in any individual with unexplained thrombosis and should be part of the work-up for patients with thrombotic disorders. Of the defects discussed, prothrombin G20210A mutation seems to be more common than antithrombin, protein C, protein S, or heparin cofactor II defects. Assessment of prothrombin gene mutation should be part of the primary evaluation of patients with unexplained thrombosis.
引用
收藏
页码:9 / +
页数:30
相关论文
共 160 条
[1]   BINDING OF THROMBIN TO ANTITHROMBIN .3. [J].
ABILDGAARD, U .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1969, 24 (01) :23-+
[2]   COMPARISON OF PROGRESSIVE ANTITHROMBIN ACTIVITY AND CONCENTRATIONS OF 3 THROMBIN INHIBITORS IN HUMAN PLASMA [J].
ABILDGAARD, U ;
FAGERHOL, MK ;
EGEBERG, O .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1970, 26 (04) :349-+
[4]  
Andersen BS, 1997, HAEMOSTASIS, V27, P157
[5]   Thrombin-inhibitor complexes in the blood during and after delivery [J].
Andersson, T ;
Lorentzen, B ;
Hogdahl, H ;
Clausen, T ;
Mowinckel, MC ;
Abildgaard, U .
THROMBOSIS RESEARCH, 1996, 82 (02) :109-117
[6]   DEEP-VEIN THROMBOSIS - DIAGNOSIS AND MANAGEMENT [J].
BAKER, WF ;
BICK, RL .
MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (03) :685-712
[7]   Treatment of hereditary and acquired thrombophilic disorders [J].
Baker, WF ;
Bick, RL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (04) :387-406
[8]   Heparin cofactor II: a new marker for pre-eclampsia [J].
Bellart, J ;
Gilabert, R ;
Cabero, L ;
Fontcuberta, J ;
Monasterio, J ;
Miralles, RM .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (02) :205-208
[9]   Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation [J].
Bellart, J ;
Gilabert, R ;
Fontcuberta, J ;
Carreras, E ;
Miralles, RM ;
Cabero, L .
AMERICAN JOURNAL OF PERINATOLOGY, 1998, 15 (02) :81-85
[10]  
Bernardi F, 1996, THROMB HAEMOSTASIS, V76, P505